Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor

Lu Deng, Ries J. Langley, Patrick H. Brown, Gang Xu, Leslie Teng, Qian Wang, Monica I. Gonzales, Glenda G. Callender, Michael I. Nishimura, Suzanne Topalian, Roy A. Mariuzza

Research output: Contribution to journalArticle

Abstract

Structural studies of complexes of T cell receptor (TCR) and peptide-major histocompatibility complex (MHC) have focused on TCRs specific for foreign antigens or native self. An unexplored category of TCRs includes those specific for self determinants bearing alterations resulting from disease, notably cancer. We determined here the structure of a human melanoma-specific TCR (E8) bound to the MHC molecule HLA-DR1 and an epitope from mutant triosephosphate isomerase. The structure had features intermediate between 'anti-foreign' and autoimmune TCR-peptide-MHC class II complexes that may reflect the hybrid nature of altered self. E8 manifested very low affinity for mutant triosephosphate isomerase-HLA-DR1 despite the highly tumor-reactive properties of E8 cells. A second TCR (G4) had even lower affinity but underwent peptide-specific formation of dimers, suggesting this as a mechanism for enhancing low-affinity TCR-peptide-MHC interactions for T cell activation.

Original languageEnglish (US)
Pages (from-to)398-408
Number of pages11
JournalNature Immunology
Volume8
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

T-Cell Antigen Receptor
Major Histocompatibility Complex
HLA-DR1 Antigen
Triose-Phosphate Isomerase
Peptides
Neoplasms
Epitopes
Melanoma
T-Lymphocytes
Antigens

ASJC Scopus subject areas

  • Immunology

Cite this

Deng, L., Langley, R. J., Brown, P. H., Xu, G., Teng, L., Wang, Q., ... Mariuzza, R. A. (2007). Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. Nature Immunology, 8(4), 398-408. https://doi.org/10.1038/ni1447

Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. / Deng, Lu; Langley, Ries J.; Brown, Patrick H.; Xu, Gang; Teng, Leslie; Wang, Qian; Gonzales, Monica I.; Callender, Glenda G.; Nishimura, Michael I.; Topalian, Suzanne; Mariuzza, Roy A.

In: Nature Immunology, Vol. 8, No. 4, 04.2007, p. 398-408.

Research output: Contribution to journalArticle

Deng, L, Langley, RJ, Brown, PH, Xu, G, Teng, L, Wang, Q, Gonzales, MI, Callender, GG, Nishimura, MI, Topalian, S & Mariuzza, RA 2007, 'Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor', Nature Immunology, vol. 8, no. 4, pp. 398-408. https://doi.org/10.1038/ni1447
Deng, Lu ; Langley, Ries J. ; Brown, Patrick H. ; Xu, Gang ; Teng, Leslie ; Wang, Qian ; Gonzales, Monica I. ; Callender, Glenda G. ; Nishimura, Michael I. ; Topalian, Suzanne ; Mariuzza, Roy A. / Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor. In: Nature Immunology. 2007 ; Vol. 8, No. 4. pp. 398-408.
@article{04ef2a44e5654fb6a17d885c326a92b9,
title = "Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor",
abstract = "Structural studies of complexes of T cell receptor (TCR) and peptide-major histocompatibility complex (MHC) have focused on TCRs specific for foreign antigens or native self. An unexplored category of TCRs includes those specific for self determinants bearing alterations resulting from disease, notably cancer. We determined here the structure of a human melanoma-specific TCR (E8) bound to the MHC molecule HLA-DR1 and an epitope from mutant triosephosphate isomerase. The structure had features intermediate between 'anti-foreign' and autoimmune TCR-peptide-MHC class II complexes that may reflect the hybrid nature of altered self. E8 manifested very low affinity for mutant triosephosphate isomerase-HLA-DR1 despite the highly tumor-reactive properties of E8 cells. A second TCR (G4) had even lower affinity but underwent peptide-specific formation of dimers, suggesting this as a mechanism for enhancing low-affinity TCR-peptide-MHC interactions for T cell activation.",
author = "Lu Deng and Langley, {Ries J.} and Brown, {Patrick H.} and Gang Xu and Leslie Teng and Qian Wang and Gonzales, {Monica I.} and Callender, {Glenda G.} and Nishimura, {Michael I.} and Suzanne Topalian and Mariuzza, {Roy A.}",
year = "2007",
month = "4",
doi = "10.1038/ni1447",
language = "English (US)",
volume = "8",
pages = "398--408",
journal = "Nature Immunology",
issn = "1529-2908",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T cell receptor

AU - Deng, Lu

AU - Langley, Ries J.

AU - Brown, Patrick H.

AU - Xu, Gang

AU - Teng, Leslie

AU - Wang, Qian

AU - Gonzales, Monica I.

AU - Callender, Glenda G.

AU - Nishimura, Michael I.

AU - Topalian, Suzanne

AU - Mariuzza, Roy A.

PY - 2007/4

Y1 - 2007/4

N2 - Structural studies of complexes of T cell receptor (TCR) and peptide-major histocompatibility complex (MHC) have focused on TCRs specific for foreign antigens or native self. An unexplored category of TCRs includes those specific for self determinants bearing alterations resulting from disease, notably cancer. We determined here the structure of a human melanoma-specific TCR (E8) bound to the MHC molecule HLA-DR1 and an epitope from mutant triosephosphate isomerase. The structure had features intermediate between 'anti-foreign' and autoimmune TCR-peptide-MHC class II complexes that may reflect the hybrid nature of altered self. E8 manifested very low affinity for mutant triosephosphate isomerase-HLA-DR1 despite the highly tumor-reactive properties of E8 cells. A second TCR (G4) had even lower affinity but underwent peptide-specific formation of dimers, suggesting this as a mechanism for enhancing low-affinity TCR-peptide-MHC interactions for T cell activation.

AB - Structural studies of complexes of T cell receptor (TCR) and peptide-major histocompatibility complex (MHC) have focused on TCRs specific for foreign antigens or native self. An unexplored category of TCRs includes those specific for self determinants bearing alterations resulting from disease, notably cancer. We determined here the structure of a human melanoma-specific TCR (E8) bound to the MHC molecule HLA-DR1 and an epitope from mutant triosephosphate isomerase. The structure had features intermediate between 'anti-foreign' and autoimmune TCR-peptide-MHC class II complexes that may reflect the hybrid nature of altered self. E8 manifested very low affinity for mutant triosephosphate isomerase-HLA-DR1 despite the highly tumor-reactive properties of E8 cells. A second TCR (G4) had even lower affinity but underwent peptide-specific formation of dimers, suggesting this as a mechanism for enhancing low-affinity TCR-peptide-MHC interactions for T cell activation.

UR - http://www.scopus.com/inward/record.url?scp=34248530182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248530182&partnerID=8YFLogxK

U2 - 10.1038/ni1447

DO - 10.1038/ni1447

M3 - Article

C2 - 17334368

AN - SCOPUS:34248530182

VL - 8

SP - 398

EP - 408

JO - Nature Immunology

JF - Nature Immunology

SN - 1529-2908

IS - 4

ER -